Jurisdiction Intelligence Report

Product Liability Case Values in Pennsylvania (2026)

Data-driven verdict and settlement analysis for Product Liability cases in Pennsylvania. Median outcome: $29.8M across 6 tracked cases.

Verdicts Tracked

Median Outcome

$29.8M

Mean Outcome

$206.8M

Range

$535K–$1100.0M

Verdict Distribution

Range	Cases	Percent
$250K–$1M	1	17%
$1M–$5M	2	33%
$5M+	3	50%

Key Valuation Factors

Severity and permanence of plaintiff injuriesScale of harm (individual claim vs. mass tort/class action)Defendant's awareness of defect and failure to warnPlaintiff's degree of comparative fault relative to 50% barType of product and regulatory compliance history

Key Trends & Insights

Pennsylvania product liability verdicts and settlements exhibit extreme variability, with outcomes ranging from $535K to $1.1B and a mean of $206.8M that is dramatically skewed by the landmark Philips Respironics CPAP recall litigation—one of the largest mass tort settlements in recent memory. The significant gap between the median ($29.8M) and mean ($206.8M) underscores that while most cases resolve in the tens of millions, catastrophic mass tort or class-action scenarios can produce outlier results that dwarf typical outcomes. Pennsylvania's plaintiff-favorable jury pool, absence of non-economic damage caps, and modified comparative fault threshold at 50% collectively create an environment where well-supported claims—particularly those involving widespread consumer harm or pharmaceutical products—carry substantial verdict risk for defendants.

Notable Cases

Personal injury claimants v. Philips Respironics (CPAP recall litigation) $1100.0M

2024 · Expert Institute

Philips agreed to a settlement resolving personal-injury claims tied to recalled CPAP/sleep-apnea devices alleged to emit toxic chemicals as sound-abatement foam degraded. The source notes the settlement included medical monitoring funding and that Philips did not admit liability.

View Source →

Melissen v. Monsanto Co. $78.0M

2024 · TopVerdict.com

TopVerdict lists this as a product-liability/toxic-exposure case with failure-to-warn and design-defect theories. The list entry provides the amount, state, and attorney names but not a specific court.

View Source →

Stange, T. v. Janssen Pharmaceuticals $535K

2018 · vLex

<cite index="15-30,15-31">Timothy Stange developed gynecomastia after taking Risperdal for Tourette's syndrome. The jury awarded $500,000 in compensatory damages</cite>, <cite index="15-33">which was molded to $535,106.17 including delay damages</cite>.

View Source →

Pledger, P. v. Janssen Pharmaceuticals, Inc. $2.5M

2018 · Expert Institute

<cite index="33-20">Austin Pledger developed gynecomastia after taking Risperdal for autism-related behavioral issues. The jury awarded $2.5 million in damages</cite>. <cite index="32-1">This was upheld by the Pennsylvania Superior Appeals Court</cite>.

View Source →

American Honda Motor Co. v. Martinez, C. $55.3M

2017 · Houston Harbaugh

A Pennsylvania jury awarded Carlos Martinez $55.3 million after he was paralyzed in a rollover accident, alleging that Honda's defective seatbelt design failed to prevent his head from hitting the roof during the crash. The verdict was affirmed by the Pennsylvania Superior Court in 2017.

View Source →

Get Your Case Evaluated

Use Harlan's AI-powered engine to analyze your Product Liability case in Pennsylvania against this verdict data.

Evaluate My Case →